Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

Hospitalizations for Chronic Obstructive Pulmonary Disease (COPD) have spiked by 50% in Bhopal, India, compared to 2022.

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...

The authors also examined outcomes among a subgroup of high-risk patients (defined as age 65 years or older with asthma, ...

Doctors and hospitals in Delhi-NCR said they are seeing a three-fold jump in patients reporting respiratory ailments ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...